Expanding HOPE Liver
for HIV Infection
Sites in New York +1 more location
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All·Age: 18+
Code: NCT07778459·Recruiting·Listed Aug 21, 2026
Clinical Trials at Icahn School of Medicine at Mount Sinai
As of August 2026, 229 paid clinical trials are recruiting at Icahn School of Medicine at Mount Sinai, located at 1 GUSTAVE L LEVY PLACE, NEW YORK, NY 10029, phone (212) 241-9065 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC
for HCC
Sites in New York +6 more locations
Sponsor: Geneos Therapeutics
Sex: All·Age: 18+
Code: NCT07722741·Phase 2·Recruiting·Listed Jul 23, 2026
231 clinical trials at Icahn School of Medicine at Mount Sinai
·Clear filters· Get a weekly email when new trials open in New York, NY.
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for Obesity or Overweight
Sites in New York, Rochester +41 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07575399·Phase 3·Recruiting·Listed May 2026
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
for Urothelial Cancer
Drug: PF-08634404
Sites in New York, Albany +131 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridoides Difficile Associated Disease
Sites in New York, Brooklyn +138 more locations
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in New York, The Bronx +69 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
for Severe Hypertriglyceridemia
Drug: Solbinsiran
Sites in New York +28 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07269210·Phase 2·Recruiting·Listed Dec 2025
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in New York, Brooklyn +35 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in New York, Jackson Heights +192 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in New York, Mineola +86 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
for Metabolic Dysfunction Associated Steatohepatitis (MASH)
Drug: Survodutide
Sites in New York, Brooklyn +161 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for Colitis, Ulcerative
Sites in New York, Carmel +48 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 12+
Code: NCT07196748·Phase 3·Recruiting·Listed Sep 2025
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
for Metabolic Dysfunction Associated Steatohepatitis
Drug: Survodutide
Sites in New York, Brooklyn +124 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06632457·Phase 3·Recruiting·Listed Oct 2024
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for Triple-Negative Breast Cancer
Sites in New York, Westbury +79 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06393374·Phase 3·Recruiting·Listed May 2024
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for Urothelial Carcinoma
Sites in New York, Long Island City +141 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04879329·Phase 2·Recruiting·Listed May 2021
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for Heart Failure
Drug: Empagliflozin
Sites in New York +85 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06935370·Phase 3·Recruiting·Listed Apr 2025
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for Urinary Bladder Neoplasms
Sites in New York, The Bronx +39 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05614739·Phase 1·Recruiting·Listed Nov 2022
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for PIK3CA Mutation
Sites in New York +51 more locations
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06982521·Phase 3·Recruiting·Listed May 2025
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
Sites in New York, Buffalo +40 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for Breast Cancer
Sites in New York, The Bronx +57 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
for Non-muscle Invasive Bladder Cancer
Sites in New York, Uniondale +52 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07206225·Phase 1·Recruiting·Listed Oct 2025
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
Sites in New York, Albany +76 more locations
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
for Hypertension
Sites in New York, Rochester +54 more locations
Sponsor: Orchestra BioMed, Inc
Sex: All·Age: 18+
Code: NCT06059638·Recruiting·Listed Sep 2023
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
for Cachexia
Drug: ponsegromab
Sites in New York, Rochester +81 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06989437·Phase 2, Phase 3·Recruiting·Listed May 2025
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for Diffuse Large B-Cell Lymphoma
Drug: Rituximab
Sites in New York, Albany +43 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06717347·Phase 3·Recruiting·Listed Dec 2024
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for Carcinoma, Non-Small-Cell Lung
Drug: Intismeran autogene
Sites in New York, The Bronx +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
for Non-small Cell Lung Cancer
Drug: Intismeran autogene
Sites in New York, The Bronx +56 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06077760·Phase 3·Recruiting·Listed Oct 2023
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for Urothelial Cancer
Sites in New York +32 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07106762·Phase 2, Phase 3·Recruiting·Listed Aug 2025
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for Heart Failure With Preserved Ejection Fraction
Sites in New York, Staten Island +108 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in New York, Mineola +44 more locations
Sponsor: Celgene
Sex: Male·Age: 18+
Code: NCT06764485·Phase 3·Recruiting·Listed Jan 2025
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for Ulcerative Colitis
Drug: Tirzepatide
Sites in New York, Yonkers +35 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 70
Code: NCT06937086·Phase 3·Recruiting·Listed Apr 2025
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
Sites in New York, Williamsville +47 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for Autosomal Dominant Polycystic Kidney Disease
Sites in New York +36 more locations
Sponsor: Calico Life Sciences LLC
Sex: All·Age: 18 - 55
Code: NCT06902558·Phase 2·Recruiting·Listed Mar 2025
SELUTION 4 De Novo Small Vessel IDE Trial
for Coronary Artery Disease
Sites in New York, Stony Brook +62 more locations
Sponsor: M.A. Med Alliance S.A.
Sex: All·Age: 18+
Code: NCT05946629·Recruiting·Listed Jul 2023
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for Immunoglobulin A Nephropathy (IgAN)
Sites in New York, The Bronx +22 more locations
Sponsor: Biogen
Sex: All·Age: 18+
Code: NCT06935357·Phase 3·Recruiting·Listed Apr 2025
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for Myelofibrosis
Sites in New York, The Bronx +28 more locations
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
for Progressive Pulmonary Fibrosis
Sites in New York +25 more locations
Sponsor: Avalyn Pharma Inc.
Sex: All·Age: 18+
Code: NCT06951217·Phase 2·Recruiting·Listed Apr 2025
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
Sites in New York, Rochester +40 more locations
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for Non-Small Cell Lung Cancer, NSCLC
Sites in New York, Westbury +26 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06162221·Phase 1, Phase 2·Recruiting·Listed Dec 2023
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for Ovarian Cancer
Drug: Bevacizumab
Sites in New York +31 more locations
Sponsor: Daiichi Sankyo
Sex: Female·Age: 18+
Code: NCT06819007·Phase 3·Recruiting·Listed Feb 2025
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for Treatment Resistant Depression
Sites in New York, Woodbury +51 more locations
Sponsor: LivaNova
Sex: All·Age: 18+
Code: NCT03887715·Recruiting·Listed Mar 2019
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
for Metastatic Breast Cancer
Sites in New York +30 more locations
Sponsor: LeonaBio
Sex: All·Age: 18+
Code: NCT05696626·Phase 3·Recruiting·Listed Jan 2023
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (45 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (42 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,389 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (45), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,136), Neurology & pain (198), Cardiovascular (194). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Icahn School of Medicine at Mount Sinai?
Icahn School of Medicine at Mount Sinai is located at 1 GUSTAVE L LEVY PLACE, NEW YORK, NY 10029. Use the Google Maps link in the intro above to get directions.
How do I contact Icahn School of Medicine at Mount Sinai?
You can reach Icahn School of Medicine at Mount Sinai by phone at (212) 241-9065. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in New York
The Bronx, NY(561)Rochester, NY(475)Buffalo, NY(416)Commack, NY(322)Harrison, NY(302)Uniondale, NY(227)Brooklyn, NY(205)Syracuse, NY(177)Stony Brook, NY(171)Albany, NY(162)Lake Success, NY(146)New Hyde Park, NY(120)Mineola, NY(117)Manhasset, NY(101)Valhalla, NY(99)Rockville Centre, NY(83)Staten Island, NY(77)East Syracuse, NY(57)Mount Kisco, NY(43)White Plains, NY(42)Amherst, NY(37)Bay Shore, NY(33)Flushing, NY(32)Roslyn, NY(32)Westbury, NY(32)Great Neck, NY(31)Webster, NY(29)Poughkeepsie, NY(26)Shirley, NY(26)Queens, NY(25)Sleepy Hollow, NY(24)Long Island City, NY(23)Ithaca, NY(22)Williamsville, NY(21)Glens Falls, NY(19)Garden City, NY(17)New Windsor, NY(17)West Islip, NY(17)Camillus, NY(16)Jamaica, NY(16)Cedarhurst, NY(15)Greenlawn, NY(15)Cooperstown, NY(14)Liverpool, NY(14)Manhattan, NY(14)Binghamton, NY(13)Hawthorne, NY(13)Laurelton, NY(13)Oswego, NY(13)Verona, NY(13)Clifton Park, NY(12)Port Jefferson Station, NY(12)Glen Oaks, NY(11)Rego Park, NY(11)East Hills, NY(10)Syosset, NY(10)East White Plains, NY(9)Huntington, NY(9)Oceanside, NY(9)Old Westbury, NY(9)